View More Recent Stories

Jul 24, 2024 06:32AM SAGE Therapeutics (SAGE) and Biogen (BIIB) Report Topline Results from Phase 2 KINETIC 2 Study of SAGE-324
Jul 19, 2024 06:36AM Sage Therapeutics (SAGE) PT Lowered to $16 at Mizuho
Jul 3, 2024 06:44AM H.C. Wainwright Reiterates Neutral Rating on Sage Therapeutics (SAGE)
Jun 13, 2024 02:32PM Scotiabank Reiterates Sector Outperform Rating on Sage Therapeutics (SAGE)
Jun 12, 2024 05:59AM BofA Securities Reiterates Underperform Rating on Sage Therapeutics (SAGE)
Jun 11, 2024 02:07PM TD Cowen Reiterates Buy Rating on Sage Therapeutics (SAGE)
Jun 11, 2024 09:14AM Citi Reiterates Sell Rating on Sage Therapeutics (SAGE)
Jun 11, 2024 06:31AM SAGE Therapeutics (SAGE) Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease
View More Recent Stories